Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 626 items for :

  • Refine by access: All content x
Clear All
Theodoros Karantanos General Internal Medicine Department, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA

Search for other papers by Theodoros Karantanos in
Google Scholar
PubMed Close
,
Styliani Karanika Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

Search for other papers by Styliani Karanika in
Google Scholar
PubMed Close
, and
Gretchen Gignac Hematology-Oncology Department, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA

Search for other papers by Gretchen Gignac in
Google Scholar
PubMed Close

( Flanagan et al . 2011 ). Obesity, hyperlipidemia, hyperinsulinemia and diabetes at the time of PCa diagnosis are associated with increased disease-associated mortality ( Hammarsten & Hogstedt 2005 , Ma et al . 2008 ). Thus, metabolic abnormalities

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0222
Volume/Issue:
Volume 23: Issue 9
Free access
Rafael Ríos Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Rafael Ríos in
Google Scholar
PubMed Close
,
Carmen Belén Lupiañez Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Carmen Belén Lupiañez in
Google Scholar
PubMed Close
,
Daniele Campa Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Daniele Campa in
Google Scholar
PubMed Close
,
Alessandro Martino Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Alessandro Martino in
Google Scholar
PubMed Close
,
Joaquin Martínez-López Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Joaquin Martínez-López in
Google Scholar
PubMed Close
,
Manuel Martínez-Bueno Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Manuel Martínez-Bueno in
Google Scholar
PubMed Close
,
Judit Varkonyi Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Judit Varkonyi in
Google Scholar
PubMed Close
,
Ramón García-Sanz Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Ramón García-Sanz in
Google Scholar
PubMed Close
,
Krzysztof Jamroziak Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Krzysztof Jamroziak in
Google Scholar
PubMed Close
,
Charles Dumontet Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Charles Dumontet in
Google Scholar
PubMed Close
,
Andrés Jerez Cayuela Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Andrés Jerez Cayuela in
Google Scholar
PubMed Close
,
Marzena Wętek Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Marzena Wętek in
Google Scholar
PubMed Close
,
Stephano Landi Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Stephano Landi in
Google Scholar
PubMed Close
,
Anna Maria Rossi Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Anna Maria Rossi in
Google Scholar
PubMed Close
,
Fabienne Lesueur Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Fabienne Lesueur in
Google Scholar
PubMed Close
,
Rui Manuel Reis Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Rui Manuel Reis in
Google Scholar
PubMed Close
,
Victor Moreno Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Victor Moreno in
Google Scholar
PubMed Close
,
Herlander Marques Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Herlander Marques in
Google Scholar
PubMed Close
,
Artur Jurczyszyn Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Artur Jurczyszyn in
Google Scholar
PubMed Close
,
Vibeke Andersen Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Vibeke Andersen in
Google Scholar
PubMed Close
,
Ulla Vogel Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Ulla Vogel in
Google Scholar
PubMed Close
,
Gabriele Buda Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Gabriele Buda in
Google Scholar
PubMed Close
,
Enrico Orciuolo Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Enrico Orciuolo in
Google Scholar
PubMed Close
,
Svend E H Jacobsen Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Svend E H Jacobsen in
Google Scholar
PubMed Close
,
Mario Petrini Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Mario Petrini in
Google Scholar
PubMed Close
,
Annette J Vangsted Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Annette J Vangsted in
Google Scholar
PubMed Close
,
Federica Gemignani Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Federica Gemignani in
Google Scholar
PubMed Close
,
Federico Canzian Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Federico Canzian in
Google Scholar
PubMed Close
,
Manuel Jurado Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Manuel Jurado in
Google Scholar
PubMed Close
, and
Juan Sainz Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain
Genomic Oncology Area, Hematology Department, Genomic Epidemiology Group, Department of Biology, Department of Hematology, Area of Genomic Medicine, Semmelweis University, Haematology Department, Medical University of Lodz, INSERM UMR 1052/CNRS 5286, Morales Meseguer General University Hospital, Haematoloy Clinik, INSERM, Life and Health Sciences Research Institute (ICVS), ICVS/3B's – PT Government Associate Laboratory, Molecular Oncology Research Center, IDIBELL – Catalan Institute of Oncology, Department of Hematology, Organ Center, Faculty of Health Sciences, UO Hematology, Clinic of Biochemistry and Immunology, Department of Haematology, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, Spain

Search for other papers by Juan Sainz in
Google Scholar
PubMed Close

toxins as well as type 2 diabetes (T2D) and obesity have been suggested as important mediators of the complex process of myelomagenesis ( Alexander et al . 2007 , Lope et al . 2008 , Wallin & Larsson 2011 ). Among these latter preventable factors, T2D

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-15-0029
Volume/Issue:
Volume 22: Issue 4
Free access
Liyan Zhou Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Liyan Zhou in
Google Scholar
PubMed Close
,
Guiying Bai Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Guiying Bai in
Google Scholar
PubMed Close
,
Yue Song Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Yue Song in
Google Scholar
PubMed Close
,
Xiaohui Liu Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Xiaohui Liu in
Google Scholar
PubMed Close
,
Xiaoqing Li Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Xiaoqing Li in
Google Scholar
PubMed Close
,
Yilin Deng Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Yilin Deng in
Google Scholar
PubMed Close
,
Yiran Si Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Yiran Si in
Google Scholar
PubMed Close
,
Yehui Shi Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Yehui Shi in
Google Scholar
PubMed Close
, and
Hongli Li Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Search for other papers by Hongli Li in
Google Scholar
PubMed Close

of breast cancer is increased by 20–28% in patients with diabetes, and that diabetes is an independent risk factor for poor prognosis of breast cancer ( Lu et al. 2023 ). A population-based study suggested that the breast cancer-specific mortality

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0330
Volume/Issue:
Volume 31: Issue 9
Restricted access
YunFeng Cui Department of Surgery, Department of Surgery, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Surgery, Department of Surgery, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Search for other papers by YunFeng Cui in
Google Scholar
PubMed Close
and
Dana K Andersen Department of Surgery, Department of Surgery, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Search for other papers by Dana K Andersen in
Google Scholar
PubMed Close

pancreatitis (CP), and diabetes mellitus (DM). The recent increase in the prevalence of type 2 DM (T2DM) is thought to have contributed to a parallel rise in the incidence of PC. Roughly half of all PC patients are found to have DM at the time of diagnosis, and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0105
Volume/Issue:
Volume 19: Issue 5
Free access
Paolo Vigneri Section of General Pathology, Section of Endocrinology, Department of Biomedical Sciences

Search for other papers by Paolo Vigneri in
Google Scholar
PubMed Close
,
Francesco Frasca Section of General Pathology, Section of Endocrinology, Department of Biomedical Sciences

Search for other papers by Francesco Frasca in
Google Scholar
PubMed Close
,
Laura Sciacca Section of General Pathology, Section of Endocrinology, Department of Biomedical Sciences

Search for other papers by Laura Sciacca in
Google Scholar
PubMed Close
,
Giuseppe Pandini Section of General Pathology, Section of Endocrinology, Department of Biomedical Sciences

Search for other papers by Giuseppe Pandini in
Google Scholar
PubMed Close
, and
Riccardo Vigneri Section of General Pathology, Section of Endocrinology, Department of Biomedical Sciences

Search for other papers by Riccardo Vigneri in
Google Scholar
PubMed Close

Introduction Diabetes mellitus (DM) is a serious and growing health problem worldwide and is associated with severe acute and chronic complications that negatively influence both the quality of life and survival of affected individuals. Today, 250

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-09-0087
Volume/Issue:
Volume 16: Issue 4
Free access
Xilin Yang Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Xilin Yang in
Google Scholar
PubMed Close
,
Ying Wang Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Ying Wang in
Google Scholar
PubMed Close
,
Andrea O Y Luk Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Andrea O Y Luk in
Google Scholar
PubMed Close
,
Wing Yee So Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Wing Yee So in
Google Scholar
PubMed Close
,
Ronald C W Ma Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Ronald C W Ma in
Google Scholar
PubMed Close
,
Alice P S Kong Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Alice P S Kong in
Google Scholar
PubMed Close
,
Gang Xu Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Gang Xu in
Google Scholar
PubMed Close
, and
Juliana C N Chan Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity , Li Ka Shing Institute of Health Sciences, Department of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Search for other papers by Juliana C N Chan in
Google Scholar
PubMed Close

Introduction Diabetes is a global epidemic with rapid increase in Asia ( Chan et al . 2009 ). In China, 9.7% of adult men and women had diabetes in 2007–2008 ( Yang et al . 2010 b ). Apart from lifestyle changes, many developing areas are

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0290
Volume/Issue:
Volume 20: Issue 2
Free access
Mathis Grossmann
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed Close
and
Gary Wittert Department of Medicine Austin Health, Discipline of Medicine, University of Melbourne, Studley Road, Heidelberg, Victoria 3084, Australia

Search for other papers by Gary Wittert in
Google Scholar
PubMed Close

Introduction Diabetes and prostate cancer (PCa) are two major, growing health problems that affect millions of men worldwide. PCa is the most common solid organ cancer in men in the USA, Canada and Australia, and the second most common cancer in men

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0067
Volume/Issue:
Volume 19: Issue 5
Free access
Carolyn A Allan MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia

Search for other papers by Carolyn A Allan in
Google Scholar
PubMed Close
,
Veronica R Collins MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia

Search for other papers by Veronica R Collins in
Google Scholar
PubMed Close
,
Mark Frydenberg MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia

Search for other papers by Mark Frydenberg in
Google Scholar
PubMed Close
,
Robert I McLachlan MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia

Search for other papers by Robert I McLachlan in
Google Scholar
PubMed Close
, and
Kati L Matthiesson MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia
MIMR-PHI Institute of Medical Research 27–31 Wright Street, Clayton, Victoria 3168, Australia

Andrology Australia School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia

Department of Endocrinology Monash Health, Melbourne, Victoria, Australia

Departments of Obstetrics and Gynaecology

Surgery Monash University, Clayton, Victoria, Australia

Department of Urology

Medical Program Monash Health, Melbourne, Victoria, Australia

Search for other papers by Kati L Matthiesson in
Google Scholar
PubMed Close

cardiovascular disease (CVD) was similar to that from prostate cancer ( Ketchandji et al . 2009 ). Men with early-stage disease (representing 75% of all men diagnosed with prostate cancer) were more likely to die from CVD than prostate cancer, with diabetes and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-13-0467
Volume/Issue:
Volume 21: Issue 4
Free access
F Castinetti Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), and Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares de l’Hypophyse HYPO, Marseille, France

Search for other papers by F Castinetti in
Google Scholar
PubMed Close
,
F Albarel Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), and Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares de l’Hypophyse HYPO, Marseille, France

Search for other papers by F Albarel in
Google Scholar
PubMed Close
,
F Archambeaud Service de Médecine Interne B – Endocrinologie, Limoges Cedex, France

Search for other papers by F Archambeaud in
Google Scholar
PubMed Close
,
J Bertherat Hôpital Cochin, Service d’Endocrinologie et Maladies Métaboliques, Paris Cedex 14, France

Search for other papers by J Bertherat in
Google Scholar
PubMed Close
,
B Bouillet CHU Dijon, Hôpital François Mitterrand, Service d’Endocrinologie, Diabétologie, Maladies Métaboliques, Dijon Cedex, France
Unité INSERM LNC-UMR 1231, Université de Bourgogne, Dijon, France

Search for other papers by B Bouillet in
Google Scholar
PubMed Close
,
P Buffier CHU Dijon, Hôpital François Mitterrand, Service d’Endocrinologie, Diabétologie, Maladies Métaboliques, Dijon Cedex, France

Search for other papers by P Buffier in
Google Scholar
PubMed Close
,
C Briet Institut MITOVASC, INSERM U1083, Angers University, Department of Endocrinology, Diabetology and Nutrition, University Medical Center, Angers, France

Search for other papers by C Briet in
Google Scholar
PubMed Close
,
B Cariou Department of Endocrinology, L’Institut du Thorax, CHU Nantes, Nantes, France

Search for other papers by B Cariou in
Google Scholar
PubMed Close
,
Ph Caron CHU de Toulouse – Hôpital Larrey – Service d’Endocrinologie – Maladies métaboliques – Nutrition, TSA 30030, Toulouse Cedex 9, France

Search for other papers by Ph Caron in
Google Scholar
PubMed Close
,
O Chabre CHU de Grenoble – Hôpital Albert Michallon, Service d’Endocrinologie-Diabétologie-Nutrition, Grenoble Cedex 9, France

Search for other papers by O Chabre in
Google Scholar
PubMed Close
,
Ph Chanson Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, et UMR S-1185 Faculté de Médecine Paris-Sud, University of Paris-Saclay, Le Kremlin-Bicêtre, France

Search for other papers by Ph Chanson in
Google Scholar
PubMed Close
,
C Cortet CHRU de Lille – Hopital Huriez, Service d’Endocrinologie, Lille Cedex, France

Search for other papers by C Cortet in
Google Scholar
PubMed Close
,
C Do Cao CHRU de Lille – Hopital Huriez, Service d’Endocrinologie, Lille Cedex, France

Search for other papers by C Do Cao in
Google Scholar
PubMed Close
,
D Drui Department of Endocrinology, L’Institut du Thorax, CHU Nantes, Nantes, France

Search for other papers by D Drui in
Google Scholar
PubMed Close
,
M Haissaguerre CHU de Bordeaux – Hôpital du Haut Lévêque, Service d’Endocrinologie-Diabétologie et Maladies Métaboliques, Pessac Cedex, France

Search for other papers by M Haissaguerre in
Google Scholar
PubMed Close
,
S Hescot Institut Curie, Oncologie Endocrinienne, Saint Cloud, France

Search for other papers by S Hescot in
Google Scholar
PubMed Close
,
F Illouz Department of Endocrinology, Diabetes and Nutrition, Reference Centre of Rare Thyroid Disease, Hospital of Angers, Angers Cedex 09, France

Search for other papers by F Illouz in
Google Scholar
PubMed Close
,
E Kuhn Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, et UMR S-1185 Faculté de Médecine Paris-Sud, University of Paris-Saclay, Le Kremlin-Bicêtre, France

Search for other papers by E Kuhn in
Google Scholar
PubMed Close
,
N Lahlou Département d’Hormonologie Spécialisée, BPR-AS, Pannes, France

Search for other papers by N Lahlou in
Google Scholar
PubMed Close
,
E Merlen CHRU de Lille – Hopital Huriez, Service d’Endocrinologie, Lille Cedex, France

Search for other papers by E Merlen in
Google Scholar
PubMed Close
,
V Raverot Hospices Civils de Lyon, Laboratoire d’Hormonologie, Service de Biochimie et Biologie Moléculaire, Groupement Hospitalier Est, Lyon, France

Search for other papers by V Raverot in
Google Scholar
PubMed Close
,
S Smati Department of Endocrinology, L’Institut du Thorax, CHU Nantes, Nantes, France

Search for other papers by S Smati in
Google Scholar
PubMed Close
,
B Verges CHU Dijon, Hôpital François Mitterrand, Service d’Endocrinologie, Diabétologie, Maladies Métaboliques, Dijon Cedex, France
Unité INSERM LNC-UMR 1231, Université de Bourgogne, Dijon, France

Search for other papers by B Verges in
Google Scholar
PubMed Close
, and
F Borson-Chazot Hospices Civils de Lyon, Fédération d’Endocrinologie, Université Claude Bernard Lyon 1, Lyon, France

Search for other papers by F Borson-Chazot in
Google Scholar
PubMed Close

the management of side effects of these treatments ( Haanen et al. 2017 ), there have been to date no recommendations from specialist societies on the management of endocrinopathies or diabetes induced by ICPI, with the exception of the management of

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-18-0320
Volume/Issue:
Volume 26: Issue 2
Open access
Prue J Hardefeldt Sydney Medical School Nepean, The Whiteley-Martin Research Centre, Discipline of Surgery, Nepean Hospital, The University of Sydney, Level 5, South Block, PO Box 63, Penrith, New South Wales 2751, Australia

Search for other papers by Prue J Hardefeldt in
Google Scholar
PubMed Close
,
Senarath Edirimanne Sydney Medical School Nepean, The Whiteley-Martin Research Centre, Discipline of Surgery, Nepean Hospital, The University of Sydney, Level 5, South Block, PO Box 63, Penrith, New South Wales 2751, Australia

Search for other papers by Senarath Edirimanne in
Google Scholar
PubMed Close
, and
Guy D Eslick Sydney Medical School Nepean, The Whiteley-Martin Research Centre, Discipline of Surgery, Nepean Hospital, The University of Sydney, Level 5, South Block, PO Box 63, Penrith, New South Wales 2751, Australia

Search for other papers by Guy D Eslick in
Google Scholar
PubMed Close

), smoking ( Khuder et al . 2001 , Mucha et al . 2006 ) and alcohol intake ( Key et al . 2006 ), the risk associated with specific types of diabetes mellitus is yet to be determined. In a meta-analysis published in 2007, Larsson et al . reported an

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0242
Volume/Issue:
Volume 19: Issue 6
Free access